Cargando…
Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation
Hemoglobinopathies are among the most common monogenic diseases worldwide. Approximately 1–5% of the global population are carriers for a genetic thalassemia mutation. The thalassemias are characterized by autosomal recessive inherited defects in the production of hemoglobin. They are highly prevale...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299245/ https://www.ncbi.nlm.nih.gov/pubmed/32557398 http://dx.doi.org/10.1007/s40265-020-01341-9 |